跳至主要内容
临床试验/ACTRN12620000522910
ACTRN12620000522910已完成1 期

A Phase 1 Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Formulations of PRAX-114

Praxis Precision Medicines Australia, Pty Ltd0 个研究点目标入组 85 人开始时间: 2020年4月28日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Female or male and between the ages of 18 and 55 years, inclusive.
  • - Weight of at least 50 kg with body mass index (BMI) between 18 and 30 kg/m2 (inclusive).

排除标准

  • - Ongoing or history of any psychiatric, medical or surgical condition that might jeopardize the participant’s safety or interfere with the absorption, distribution, metabolism or excretion of the study drug.
  • - Any abnormal ECG findings, laboratory value or physical examination findings
  • - Positive breath test for ethanol, urine drug screen, urine cotinine test
  • - Use of systemic prescription medications or over-the-counter (OTC) medication, including multivitamins, and dietary and herbal supplement within 2 weeks
  • - Use of any experimental or investigational drug or device within 30 days
  • - Donation or loss of =400 mL blood within 8 weeks and/or donation of plasma within 7 days

研究者

发起方
Praxis Precision Medicines Australia, Pty Ltd

相似试验

A Trial in Healthy Participants to Evaluate the... | 临床试验